Large-scale analyses of multigene panel testing recently confirmed PALB2 as a high-risk breast cancer susceptibility gene (15), and the odds ratio (OR) of PALB2 mutations for breast cancer was comparable to that of BRCA2 mutations (16). This evidence concerns the gene BRCA2 and breast carcinoma.